SavedAdd your journal

Journals / Şişli Etfal Hastanesi Tıp Bülteni / 2006 / Cilt: 40 - Sayı: 2

Diabetik nefropati tedavisi ve güncel yaklaşım

Sema UÇAK
Yüksel ALTUNTAŞ
Pages
7–11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

UÇAK, S., ALTUNTAŞ, Y. (2006). Diabetik nefropati tedavisi ve güncel yaklaşım. Şişli Etfal Hastanesi Tıp Bülteni, Cilt: 40 - Sayı: 2, 7–11. https://ajindex.com/articles/363548

References (13)

  1. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on ihe development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
  2. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patient's witlvtype 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998
  3. Shichiri M, Kishikawa H, Ohkubo. Y, Wake N: Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. Diabetes Care 23 (Suppl.2):B21-B29,2000
  4. Tarnow L, Rossing P, Gali MA, et al: Prevalence of arterial hypertension in diabetic patients before and after the JNC-V. Diabetes Care 17:1247-1251, 1994
  5. UK Prospective Diabetes Study Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 317:703-713, 1998
  6. Kvetny J, Gregersen G, Pedersen RS: Randomized placebo-controlled trial of perindopril in normotensive. normoalbüminuric patients with type 1 diabetes mellitus. Q J Med 94:89-94, 2001
  7. Ruggenenti P, Fassi A, Ilieva AP, et al. Bergamo Nephrologic Diabetes Complications Trial (BENEDICT) Investi¬gators: Preventing microalbuminuria in type 2 diabetes. N Engl J Med. 19:194.1-5.1, 2004
  8. Heart Outcomes Prevention Evaluation Study Investigators: Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 355:253-259, 2000
  9. Microalbuminuria Collaborative Study Group: Intensive therapy and progression to clinical albuminuria in patients with insulin dependent diabetes mellitus and microalbuminuria. BMJ 311:973-977, 1995
  10. Bakris G, Viberti G, Weston WM, el: al: Rosiglitazone reduces urinary albumin excretion in type II diabetes. J Hum Hypertens 17:7-12, 2003
  11. Mogensen CE: Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes. J Intern Med 254:45-66,2003
  12. The ACE Inhibitors in Diabetic Nephropathy Trialist Group: Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors'? A meta-analysis of individual patient data. Ann Intern Med 134:370-379, 2001
  13. Parving HH, Lehnert H, Bröchner-Mortensen J, et al: The effect of irbesartan on the development of diabetic nephropathy in